Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

BHVN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 16.00%

Insider Buying (Last 12 Months): $12,231,711.54

Insider Selling (Last 12 Months): $459,690.00

Biohaven Insider Trading History Chart

Biohaven Share Price & Price History

^$45.59

▲ +0.4 (0.89%)

As of 11/22/2024 01:00 AM ET

Days: 30 | 90 | 365

First JFK… next Elon?

From Porter & Company | Ad

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

Biohaven Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/2/2024	John W. Childs	Director	Buy	21,052	$47.50	$999,970.00	21,052
9/24/2024	Gregory H. Bailey	Director	Buy	5,000	$44.19	$220,950.00	1,620,071
7/18/2024	John W. Childs	Director	Buy	28,400	$35.67	$1,013,028.00	2,339,741
5/30/2024	John W. Childs	Director	Buy	28,000	$35.58	$996,240.00	2,311,341
5/13/2024	John W. Childs	Director	Buy	28,500	$35.17	$1,002,345.00	2,283,341
4/24/2024	Gregory H. Bailey	Director	Buy	25,503	$39.18	$999,207.54	1,600,071
4/22/2024	Gregory H. Bailey	Director	Buy	48,780	$41.00	$1,999,980.00	1,574,568
4/22/2024	Vlad Coric	CEO	Buy	121,951	$41.00	$4,999,991.00	1,788,417
12/29/2023	Irina Antonijevic	Director	Sell	11,000	$41.79	$459,690.00	2,535
10/5/2023	Matthew Buten	CFO	Buy	22,727	$22.00	$499,994.00	189,380
10/5/2023	Vlad Coric	CEO	Buy	113,637	$22.00	$2,500,014.00	1,657,031
10/4/2023	Gregory H. Bailey	Director	Buy	17,817	$22.57	$402,129.69	1,525,788
8/30/2023	John W. Childs	Director	Buy	50,000	$18.44	$922,000.00	1,975,118
8/4/2023	John W. Childs	Director	Buy	100,000	$19.78	$1,978,000.00	1,925,118
10/31/2022	Vlad Coric	CEO	Buy	25,800	$15.97	$412,026.00	1,543,394
10/28/2022	Vlad Coric	CEO	Buy	41,930	$14.87	$623,499.10	1,517,594
10/25/2022	Gregory H. Bailey	Director	Buy	200,000	$10.50	$2,100,000.00	1,507,971
10/25/2022	Matthew Buten	CFO	Buy	142,857	$10.50	$1,499,998.50	166,653
10/25/2022	Vlad Coric	CEO	Buy	853,380	$10.50	$8,960,490.00	1,475,664
8/19/2022	Gregory H. Bailey	Director	Buy	38,000	$148.04	$5,625,520.00	2,583,658
5/10/2022	George C. Clark	CAO	Sell	4,200	$141.50	$594,300.00	4,065
1/19/2022	George C. Clark	CAO	Sell	9,375	$117.01	$1,096,968.75
12/20/2021	George C. Clark	CAO	Sell	1,915	$123.84	$237,153.60
12/20/2021	Julia P. Gregory	Director	Sell	12,000	$125.00	$1,500,000.00
12/15/2021	Elyse Stock	Insider	Sell	21,919	$105.49	$2,312,235.31
12/10/2021	James Engelhart	CFO	Sell	35,000	$102.55	$3,589,250.00
11/29/2021	Declan Doogan	Director	Sell	24,525	$112.80	$2,766,420.00

$2 Trillion Disappears Because of Fed's Secretive New Move

From Stansberry Research | Ad

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.

Click here to see his new research now.

SEC Filings (Institutional Ownership Changes) for Biohaven (NYSE:BHVN)

88.78% of Biohaven stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Biohaven Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	1,714,612	$85.70M	0.0%	+2.6%	1.696%
11/15/2024	Barclays PLC	268,077	$13.40M	0.0%	+87.6%	0.265%
11/15/2024	Y Intercept Hong Kong Ltd	26,789	$1.34M	0.1%	N/A	0.026%
11/15/2024	XTX Topco Ltd	32,510	$1.63M	0.1%	+278.5%	0.032%
11/15/2024	Wellington Management Group LLP	243,167	$12.15M	0.0%	+600.9%	0.240%
11/15/2024	Sphera Funds Management LTD.	133,323	$6.66M	1.1%	N/A	0.132%
11/15/2024	State Street Corp	3,256,636	$162.73M	0.0%	-10.8%	3.221%
11/15/2024	Stifel Financial Corp	6,509,261	$325.27M	0.3%	+0.4%	6.437%
11/15/2024	Redmile Group LLC	1,034,219	$51.68M	3.0%	-4.9%	1.023%
11/15/2024	Point72 DIFC Ltd	7,354	$0.37M	0.0%	N/A	0.007%
11/15/2024	Point72 Asset Management L.P.	1,500,284	$74.97M	0.2%	+745.9%	1.484%
11/15/2024	Parallax Volatility Advisers L.P.	5,164	$0.26M	0.0%	N/A	0.005%
11/15/2024	Janus Henderson Group PLC	6,226,393	$311.14M	0.2%	+5.6%	6.157%
11/15/2024	HighTower Advisors LLC	5,535	$0.28M	0.0%	N/A	0.005%
11/15/2024	Holocene Advisors LP	852,627	$42.61M	0.2%	-49.7%	0.843%
11/15/2024	Bamco Inc. NY	45,000	$2.25M	0.0%	+28.6%	0.048%
11/15/2024	Erste Asset Management GmbH	51,300	$2.62M	0.0%	N/A	0.054%
11/14/2024	Fred Alger Management LLC	58,142	$2.91M	0.0%	+44.3%	0.061%
11/14/2024	Eventide Asset Management LLC	399,827	$19.98M	0.3%	-37.0%	0.423%
11/14/2024	Captrust Financial Advisors	5,862	$0.29M	0.0%	N/A	0.006%
11/14/2024	Capstone Investment Advisors LLC	5,000	$0.25M	0.0%	N/A	0.005%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	508,622	$25.42M	0.0%	+563.4%	0.538%
11/13/2024	FMR LLC	1,841,095	$92M	0.0%	-0.7%	1.947%
11/13/2024	D.A. Davidson & CO.	23,916	$1.20M	0.0%	N/A	0.025%
11/13/2024	The Manufacturers Life Insurance Company	192,677	$9.63M	0.0%	+4.8%	0.204%
11/13/2024	Canton Hathaway LLC	21,350	$1.07M	0.3%	-2.3%	0.023%
11/12/2024	Pekin Hardy Strauss Inc.	16,975	$0.85M	0.1%	+27.6%	0.018%
11/12/2024	Algert Global LLC	32,392	$1.62M	0.0%	+337.6%	0.034%
11/12/2024	Citigroup Inc.	119,905	$5.99M	0.0%	+125.8%	0.127%
11/12/2024	Charles Schwab Investment Management Inc.	632,690	$31.62M	0.0%	+5.5%	0.669%
11/9/2024	Intech Investment Management LLC	11,307	$0.57M	0.0%	N/A	0.012%
11/8/2024	Advisors Asset Management Inc.	16,558	$0.83M	0.0%	-2.0%	0.018%
11/7/2024	First Turn Management LLC	315,816	$15.78M	2.5%	-13.7%	0.334%
11/7/2024	Swiss National Bank	138,000	$6.90M	0.0%	-4.6%	0.146%
11/6/2024	KBC Group NV	2,250	$0.11M	0.0%	+24.5%	0.002%
11/5/2024	Victory Capital Management Inc.	363,615	$18.17M	0.0%	+67.1%	0.385%
11/5/2024	GSA Capital Partners LLP	4,609	$0.23M	0.0%	-70.7%	0.005%
11/4/2024	Venturi Wealth Management LLC	3,117	$0.16M	0.0%	+19.1%	0.003%
11/4/2024	Chartwell Investment Partners LLC	10,992	$0.55M	0.0%	-23.1%	0.012%
11/4/2024	State of New Jersey Common Pension Fund D	47,728	$2.39M	0.0%	-14.9%	0.050%
11/4/2024	Sigma Planning Corp	8,204	$0.41M	0.0%	-4.4%	0.009%
11/1/2024	SpiderRock Advisors LLC	12,400	$0.62M	0.0%	N/A	0.013%
10/31/2024	Principal Financial Group Inc.	74,106	$3.70M	0.0%	-6.3%	0.084%
10/29/2024	VELA Investment Management LLC	17,530	$0.88M	0.3%	+25.6%	0.020%
10/28/2024	Oak Ridge Investments LLC	21,146	$1.06M	0.1%	-3.9%	0.024%
10/28/2024	US Bancorp DE	2,173	$0.11M	0.0%	+57.1%	0.002%
10/24/2024	Nisa Investment Advisors LLC	7,687	$0.38M	0.0%	-39.7%	0.009%
10/23/2024	Values First Advisors Inc.	1,565	$78K	0.0%	N/A	0.002%
10/22/2024	Private Advisor Group LLC	7,364	$0.37M	0.0%	-3.7%	0.008%
10/18/2024	Cadent Capital Advisors LLC	35,449	$1.77M	0.5%	N/A	0.040%
10/16/2024	nVerses Capital LLC	1,000	$50K	0.0%	N/A	0.001%
10/11/2024	Creative Planning	18,209	$0.91M	0.0%	+57.9%	0.019%
10/10/2024	Exchange Traded Concepts LLC	19,893	$0.99M	0.0%	+15.9%	0.023%
10/10/2024	Inspire Investing LLC	8,197	$0.41M	0.0%	-19.2%	0.009%
10/9/2024	Cypress Wealth Services LLC	4,489	$0.22M	0.0%	N/A	0.005%
10/7/2024	Diversified Trust Co	4,790	$0.24M	0.0%	N/A	0.005%
10/5/2024	Handelsbanken Fonder AB	20,700	$1.03M	0.0%	+20.3%	0.023%
10/3/2024	SG Americas Securities LLC	16,530	$0.83M	0.0%	-34.5%	0.019%
8/27/2024	Clearbridge Investments LLC	479,369	$16.64M	0.0%	+16.9%	0.543%
8/19/2024	Point72 Asset Management L.P.	177,362	$6.16M	0.0%	-80.5%	0.201%
8/16/2024	Perceptive Advisors LLC	1,485,232	$51.55M	1.2%	-13.9%	1.682%
8/16/2024	Quarry LP	5,000	$0.17M	0.0%	+614.3%	0.006%
8/16/2024	Creative Planning	11,535	$0.40M	0.0%	-12.4%	0.013%
8/16/2024	Algert Global LLC	7,402	$0.26M	0.0%	+5.9%	0.008%
8/16/2024	Driehaus Capital Management LLC	244,421	$8.48M	0.1%	-12.8%	0.277%
8/15/2024	Susquehanna Portfolio Strategies LLC	27,227	$0.95M	0.0%	-24.8%	0.031%
8/15/2024	The Manufacturers Life Insurance Company	183,772	$6.38M	0.0%	+12.3%	0.208%
8/15/2024	AQR Capital Management LLC	54,361	$1.89M	0.0%	+234.3%	0.062%
8/15/2024	Armistice Capital LLC	1,396,968	$48.49M	0.6%	+74.8%	1.582%
8/14/2024	Squarepoint Ops LLC	17,064	$0.59M	0.0%	N/A	0.019%
8/14/2024	Fred Alger Management LLC	40,294	$1.40M	0.0%	-21.2%	0.046%
8/14/2024	Cubist Systematic Strategies LLC	97,902	$3.40M	0.0%	N/A	0.104%
8/14/2024	Marshall Wace LLP	105,568	$3.66M	0.0%	-86.5%	0.120%
8/14/2024	Logos Global Management LP	250,000	$8.68M	0.7%	N/A	0.283%
8/14/2024	Farallon Capital Management LLC	2,248,000	$78.03M	0.4%	+181.4%	2.546%
8/14/2024	Magnetar Financial LLC	59,371	$2.06M	0.0%	N/A	0.067%
8/14/2024	Hood River Capital Management LLC	368,902	$12.81M	0.3%	+9.6%	0.418%
8/14/2024	Gabelli Funds LLC	20,500	$0.71M	0.0%	-21.2%	0.023%
8/14/2024	ProShare Advisors LLC	9,164	$0.32M	0.0%	-25.4%	0.010%
8/14/2024	Profund Advisors LLC	36,239	$1.26M	0.0%	+42.4%	0.041%
8/13/2024	Transatlantique Private Wealth LLC	7,707	$0.27M	0.1%	+52.6%	0.009%
8/13/2024	Sei Investments Co.	13,895	$0.48M	0.0%	-24.6%	0.016%
8/13/2024	Public Employees Retirement Association of Colorado	7,796	$0.27M	0.0%	+114.5%	0.009%
8/12/2024	Inspire Investing LLC	10,150	$0.35M	0.0%	+57.5%	0.011%
8/12/2024	Seven Eight Capital LP	38,724	$1.34M	0.1%	N/A	0.044%
8/12/2024	Hsbc Holdings PLC	8,291	$0.29M	0.0%	+6.1%	0.009%
8/12/2024	Elkhorn Partners Limited Partnership	3,600	$0.13M	0.1%	N/A	0.004%
8/12/2024	E Fund Management Co. Ltd.	11,883	$0.41M	0.0%	+58.9%	0.013%
8/9/2024	Pekin Hardy Strauss Inc.	13,300	$0.46M	0.1%	N/A	0.015%
8/9/2024	Redwood Wealth Management Group LLC	1,750	$61K	0.0%	N/A	0.002%
8/8/2024	Federated Hermes Inc.	23,855	$0.83M	0.0%	-62.2%	0.027%
8/8/2024	First Turn Management LLC	366,019	$12.71M	2.1%	-15.3%	0.415%
8/8/2024	Nicholas Investment Partners LP	45,966	$1.60M	0.2%	-74.8%	0.052%
8/8/2024	American Century Companies Inc.	511,237	$17.75M	0.0%	+166.8%	0.579%
8/8/2024	State of New Jersey Common Pension Fund D	56,070	$1.95M	0.0%	-7.1%	0.064%
8/5/2024	Arizona State Retirement System	20,575	$0.71M	0.0%	+3.7%	0.023%
8/5/2024	Victory Capital Management Inc.	217,655	$7.56M	0.0%	+3.9%	0.247%
8/5/2024	VELA Investment Management LLC	13,958	$0.48M	0.2%	+10.2%	0.016%
8/3/2024	TD Asset Management Inc	295,842	$10.27M	0.0%	-8.1%	0.335%
8/2/2024	Simon Quick Advisors LLC	71,815	$2.49M	0.2%	-2.8%	0.081%

Data available starting January 2016

Biohaven Ltd., together with its subsidiaries, focuses on discovering, developing, and commercializing therapies for immunology, neuroscience, and oncology worldwide. The company's pipeline products include Troriluzole, which is in Phase 3 clinical trial for the treatment of neurological and neuropsychiatric illnesses; BHV-5500 that blocks glutamate signaling mediated by post-synaptic NMDA receptors; Taldefgrobep Alfa, which is in Phase 3 clinical trial for the treatment of spinal muscular atrophy and obesity; BHV-7000, a candidate in Phase 2/3 clinical trials for the treatment of focal and generalized epilepsy, bipolar disorder, and major depressive disorder; BHV-2100 that is in Phase 1 clinical trials for the treatment of migraines and neuropathic pain; and BHV-8000, a product candidate in Phase 1 clinical trials for the treatment of early Alzheimer's and Parkinson's disease, sclerosis, and amyloid-related imaging abnormalities. It also offers BHV-1300, a product candidate in Phase 1 clinical trials to treat rheumatoid arthritis; BHV-1310 for the treatment of generalized myasthenia gravis and acute exacerbations or flares; BHV-1400 to treat IgA Nephropathy; and BHV-1600 for the treatment of dilated cardiomyopathy. In addition, the company develops BHV-1100, a product candidate in Phase 1a/1b clinical trials for multiple myeloma patients; BHV-1510, a preclinical product that targets carcinomas; and BHV-1500 for Hodgkin's lymphoma. It has license, development, and commercialization agreements with Yale University, AstraZeneca, University of Connecticut, Artizan Biosciences Inc., Reliant Glycosciences LLC, Katholieke Universiteit Leuven, BMS, and Highlightll Pharmaceutical Co. Ltd. The company was formerly known as Biohaven Research Ltd and changed its name to Biohaven Ltd. in September 2022. Biohaven Ltd. was incorporated in 2022 and is headquartered in New Haven, Connecticut.

Today's Range

Now: $45.59

$44.98

$47.15

50 Day Range

MA: $49.10

$39.01

$53.73

52 Week Range

Now: $45.59

$26.80

$62.21

Volume

691,029 shs

Average Volume

746,157 shs

Market Capitalization

$4.61 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.31

Who are the company insiders with the largest holdings of Biohaven?: Biohaven's top insider shareholders include:
John W Childs (Director)
Vlad Coric (CEO)
Gregory Bailey (Director)
Matthew Buten (CFO)
Irina Antonijevic (Director)
Learn More about top insider investors at Biohaven.
Who are the major institutional investors of Biohaven?: Biohaven's top institutional shareholders include:
Stifel Financial Corp — 6.44%
Janus Henderson Group PLC — 6.16%
State Street Corp — 3.22%
FMR LLC — 1.95%
Geode Capital Management LLC — 1.70%
Point72 Asset Management L.P. — 1.48%
Learn More about top institutional investors of Biohaven stock.
Which major investors are selling Biohaven stock?: During the last quarter, BHVN stock was sold by these institutional investors:
Holocene Advisors LP
State Street Corp
Eventide Asset Management LLC
Redmile Group LLC
First Turn Management LLC
FMR LLC
GSA Capital Partners LLP
SG Americas Securities LLC
Which major investors are buying Biohaven stock?: During the last quarter, BHVN stock was bought by institutional investors including:
Point72 Asset Management L.P.
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Janus Henderson Group PLC
Ikarian Capital LLC
Wellington Management Group LLP
Victory Capital Management Inc.
Sphera Funds Management LTD.
Barclays PLC
Within the previous year, these company insiders have bought Biohaven stock:
John W Childs (Director)
Vlad Coric (CEO)
Gregory Bailey (Director)
Matthew Buten (CFO)
Learn More investors buying Biohaven stock.